Farmingdale, NY 3/6/07; 5/2/07—Cemtrex, a provider of continuous emissions monitoring systems, has acquired Griffin Filters. Griffin Filters designs, manufactures and supplies air filtration and environmental control systems, including fabric filters. “Griffin Filters has been a leading supplier of dust collection systems for the past forty years with hundreds of installations nationwide,” stated Cemtrex President and […]
Total reflectance X-ray fluorescence spectroscopy (TXRF) is a variation on the standard X-ray fluorescence technique. In both methods, the sample is irradiated with X-rays. The high energy of the X-ray photons is sufficient to knock out electrons from the inner electron shells of the atoms in the sample. As outer electrons make quantum transitions into […]
Cyntellect received a $1.3 million Phase II Small Business Innovative Research (SBIR) grant to continue development of its LEAP system for automated purification and the cloning of cells based on specific secretion of native or recombinant proteins. Fluxion Biosciences received a $1.2 million Phase II SBIR grant from the National Institutes of Health for the […]
A new report, “Pharma 2020: The Vision” from PWC finds that drug companies will change how they do R&D in the future. They will move from the current “linear” research process to “live licenses,” under which a drug is launched on a restricted basis as testing continues. Regulators worldwide will share data, resulting in a […]
The Commonwealth Scientific and Industrial Research Organization (CSIRO) will get a total of AUD 2.8 billion ($2.4 billion) over the next four years, according to Australia’s 2007–08 budget, which was released in May. CSIRO’s National Research Flagships program will receive AUD 174 million ($146.7 million) over the next four years. Specific allotments include AUD 60 […]
Pfizer announced that it will spend $300 million on R&D in South Korea by 2012. An initial agreement between South Korea’s Ministry of Health and Welfare and Pfizer for the development of drugs and medical technology was signed on June 13. According to the South Korean government, this is the largest R&D investment by a […]
Integrating organizational structures has been the focus of Horiba and Shimadzu, two of the largest analytical instrument companies. Based in Japan, both companies have sought in recent years to improve profitability through consolidating operations, new manufacturing facilities and strengthening their US businesses. As the results for each company’s most recent fiscal years show, these efforts […]
Venlo, The Netherlands and Gaithersburg, MD 6/3/07—QIAGEN NV has agreed to acquire publicly listed molecular diagnostics firm Digene for approximately $1.6 billion, including $170 million in cash. QIAGEN will offer Digene stockholders $61.25 in cash per share, a 37% premium over Digene’s June 1 closing price, or 3.545 of QIAGEN stock. QIAGEN and Digene shareholders […]
This issue, IBO has made a of couple changes to its Life Science Sales Index. Gene Logic, Tripos and Molecular Devices were removed from the Index. Tripos sold its Discovery Informatics division in March (see IBO 11/30/06), while Gene Logic increased the service orientation of its business. Molecular Devices was acquired by MDS on March […]
DeltaDOT appointed Richard Lingard as vice president of Sales. He was previously director of Strategic Alliances for Invitrogen. SRU Biosystems exclusively licensed Novartis’s Evanescent Resonance technology for drug discovery applications. The technology enables enhanced sensitivity to fluorescence-based assays. In April, Caliper Life Sciences named John DelliSanti executive vice president and chief commercial officer. He previously […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
